Drug
Aztreonam
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Eosinophilia | 183 | 31.0 | 31.8 | signal |
| 2 | Atelectasis | 72 | 21.9 | 22.2 | signal |
| 3 | Bronchospasm | 98 | 20.2 | 20.5 | signal |
| 4 | Haemoptysis | 190 | 20.1 | 20.6 | signal |
| 5 | Sleep Disorder Due To A General Medical Condition | 84 | 15.3 | 15.5 | signal |
| 6 | Toxic Epidermal Necrolysis | 71 | 13.9 | 14.0 | signal |
| 7 | Lung Infection | 74 | 13.8 | 14.0 | signal |
| 8 | Hepatic Cytolysis | 56 | 13.5 | 13.6 | signal |
| 9 | Drug Reaction With Eosinophilia And Systemic Symptoms | 114 | 13.1 | 13.3 | signal |
| 10 | Sputum Discoloured | 36 | 11.2 | 11.3 | signal |
| 11 | Rash Maculo-papular | 84 | 11.2 | 11.3 | signal |
| 12 | Sinus Disorder | 68 | 10.1 | 10.2 | signal |
| 13 | Rib Fracture | 67 | 9.6 | 9.7 | signal |
| 14 | Toxic Skin Eruption | 32 | 9.3 | 9.4 | signal |
| 15 | Agranulocytosis | 54 | 8.6 | 8.6 | signal |
| 16 | Leukocytosis | 52 | 8.5 | 8.5 | signal |
| 17 | Productive Cough | 129 | 8.0 | 8.1 | signal |
| 18 | Impaired Quality Of Life | 37 | 7.6 | 7.6 | signal |
| 19 | Hospitalisation | 390 | 7.5 | 7.9 | signal |
| 20 | Drug Resistance | 65 | 7.4 | 7.5 | signal |
| 21 | Septic Shock | 105 | 7.1 | 7.2 | signal |
| 22 | Acute Respiratory Failure | 46 | 7.1 | 7.1 | signal |
| 23 | Wheezing | 141 | 7.0 | 7.1 | signal |
| 24 | Respiratory Failure | 169 | 6.8 | 6.9 | signal |
| 25 | Hepatocellular Injury | 32 | 6.6 | 6.6 | signal |
| 26 | Cholestasis | 41 | 6.3 | 6.3 | signal |
| 27 | Blood Alkaline Phosphatase Increased | 52 | 6.1 | 6.2 | signal |
| 28 | Loss Of Personal Independence In Daily Activities | 94 | 5.8 | 5.9 | signal |
| 29 | Pneumothorax | 31 | 5.7 | 5.8 | signal |
| 30 | Renal Tubular Necrosis | 19 | 5.7 | 5.7 | signal |
| 31 | Multi-organ Failure | 33 | 5.5 | 5.5 | signal |
| 32 | Shock | 41 | 5.3 | 5.3 | signal |
| 33 | Clostridium Difficile Colitis | 19 | 5.3 | 5.3 | signal |
| 34 | Laceration | 17 | 5.2 | 5.2 | signal |
| 35 | Infection | 249 | 5.1 | 5.2 | signal |
| 36 | Obstructive Airways Disorder | 19 | 5.0 | 5.0 | signal |
| 37 | Staphylococcal Infection | 54 | 4.8 | 4.8 | signal |
| 38 | Sinus Congestion | 22 | 4.8 | 4.8 | signal |
| 39 | Secretion Discharge | 20 | 4.8 | 4.8 | signal |
| 40 | Candida Infection | 27 | 4.8 | 4.8 | signal |
| 41 | Tubulointerstitial Nephritis | 30 | 4.7 | 4.7 | signal |
| 42 | Lung Disorder | 74 | 4.4 | 4.5 | signal |
| 43 | Treatment Noncompliance | 81 | 4.4 | 4.4 | signal |
| 44 | Hypoxia | 52 | 4.4 | 4.4 | signal |
| 45 | Respiratory Tract Congestion | 23 | 4.2 | 4.3 | signal |
| 46 | Pulmonary Congestion | 19 | 4.2 | 4.2 | signal |
| 47 | Aggression | 71 | 4.2 | 4.2 | signal |
| 48 | Bacterial Infection | 26 | 4.1 | 4.1 | signal |
| 49 | Chest Discomfort | 139 | 4.0 | 4.1 | signal |
| 50 | Aphonia | 18 | 3.8 | 3.8 | signal |
| 51 | Cough | 359 | 3.8 | 3.9 | signal |
| 52 | Respiratory Distress | 35 | 3.7 | 3.7 | signal |
| 53 | Posterior Reversible Encephalopathy Syndrome | 12 | 3.7 | 3.7 | signal |
| 54 | Malnutrition | 14 | 3.7 | 3.7 | signal |
| 55 | Clostridium Difficile Infection | 27 | 3.7 | 3.7 | signal |
| 56 | Therapeutic Product Effect Incomplete | 85 | 3.5 | 3.6 | signal |
| 57 | Urosepsis | 11 | 3.5 | 3.5 | signal |
| 58 | Viral Infection | 39 | 3.4 | 3.5 | signal |
| 59 | Hyperbilirubinaemia | 12 | 3.4 | 3.4 | signal |
| 60 | Coagulopathy | 19 | 3.4 | 3.4 | signal |
| 61 | Asthma | 128 | 3.4 | 3.4 | signal |
| 62 | Acute Respiratory Distress Syndrome | 20 | 3.3 | 3.3 | signal |
| 63 | Aspartate Aminotransferase Increased | 60 | 3.3 | 3.3 | signal |
| 64 | Alanine Aminotransferase Increased | 69 | 3.3 | 3.3 | signal |
| 65 | Respiratory Disorder | 32 | 3.1 | 3.1 | signal |
| 66 | Small Intestinal Obstruction | 13 | 3.1 | 3.1 | signal |
| 67 | Insurance Issue | 15 | 3.0 | 3.0 | signal |
| 68 | Thrombocytopenia | 112 | 2.9 | 3.0 | signal |
| 69 | Premature Delivery | 16 | 2.9 | 2.9 | signal |
| 70 | Circulatory Collapse | 17 | 2.9 | 2.9 | signal |
| 71 | Stevens-johnson Syndrome | 22 | 2.9 | 2.9 | signal |
| 72 | Sepsis | 110 | 2.9 | 2.9 | signal |
| 73 | Liver Function Test Increased | 21 | 2.9 | 2.9 | signal |
| 74 | Heart Rate Increased | 97 | 2.9 | 2.9 | signal |
| 75 | End Stage Renal Disease | 18 | 2.9 | 2.9 | signal |
| 76 | Drug Eruption | 17 | 2.8 | 2.8 | signal |
| 77 | Influenza | 107 | 2.8 | 2.8 | signal |
| 78 | Transaminases Increased | 21 | 2.8 | 2.8 | signal |
| 79 | Face Oedema | 16 | 2.8 | 2.8 | signal |
| 80 | Acute Kidney Injury | 143 | 2.8 | 2.8 | signal |
| 81 | Bacteraemia | 11 | 2.7 | 2.7 | signal |
| 82 | Multiple Organ Dysfunction Syndrome | 26 | 2.7 | 2.7 | signal |
| 83 | Thrombotic Microangiopathy | 9 | 2.7 | 2.7 | signal |
| 84 | Respiratory Tract Infection | 24 | 2.7 | 2.7 | signal |
| 85 | Lymphopenia | 13 | 2.7 | 2.7 | signal |
| 86 | Pneumonia | 297 | 2.7 | 2.8 | signal |
| 87 | Atrial Fibrillation | 89 | 2.7 | 2.7 | signal |
| 88 | Drug Level Increased | 15 | 2.7 | 2.7 | signal |
| 89 | Drug Intolerance | 85 | 2.6 | 2.6 | signal |
| 90 | Renal Failure | 118 | 2.6 | 2.6 | signal |
| 91 | Febrile Neutropenia | 58 | 2.6 | 2.6 | signal |
| 92 | General Physical Health Deterioration | 99 | 2.5 | 2.6 | signal |
| 93 | Blood Test Abnormal | 12 | 2.5 | 2.5 | signal |
| 94 | Disseminated Intravascular Coagulation | 12 | 2.5 | 2.5 | signal |
| 95 | Pyrexia | 294 | 2.5 | 2.6 | signal |
| 96 | Illness | 85 | 2.5 | 2.5 | signal |
| 97 | Ventricular Tachycardia | 14 | 2.5 | 2.5 | signal |
| 98 | Rash Generalised | 22 | 2.5 | 2.5 | signal |
| 99 | Drug Hypersensitivity | 162 | 2.4 | 2.5 | signal |
| 100 | Blood Urea Increased | 14 | 2.4 | 2.4 | signal |
| 101 | Blood Bilirubin Increased | 22 | 2.4 | 2.4 | signal |
| 102 | Generalised Tonic-clonic Seizure | 13 | 2.3 | 2.3 | signal |
| 103 | Throat Irritation | 35 | 2.3 | 2.3 | signal |
| 104 | Dyspnoea | 440 | 2.3 | 2.4 | signal |
| 105 | Intestinal Obstruction | 29 | 2.3 | 2.3 | signal |
| 106 | Hepatic Enzyme Increased | 52 | 2.2 | 2.3 | signal |
| 107 | Oxygen Saturation Decreased | 42 | 2.2 | 2.2 | signal |
| 108 | Sudden Death | 8 | 2.2 | 2.2 | signal |
| 109 | Renal Failure Acute | 32 | 2.2 | 2.2 | signal |
| 110 | C-reactive Protein Increased | 27 | 2.2 | 2.2 | signal |
| 111 | Ill-defined Disorder | 45 | 2.2 | 2.2 | signal |
| 112 | Exposure During Pregnancy | 45 | 2.1 | 2.1 | signal |
| 113 | Fungal Infection | 24 | 2.1 | 2.1 | signal |
| 114 | Musculoskeletal Chest Pain | 11 | 2.1 | 2.1 | signal |
| 115 | Condition Aggravated | 214 | 2.1 | 2.1 | signal |
| 116 | Pneumonitis | 19 | 2.1 | 2.1 | signal |
| 117 | Cardiogenic Shock | 10 | 2.1 | 2.1 | signal |
| 118 | Brain Injury | 7 | 2.0 | 2.0 | no signal |
| 119 | Encephalopathy | 17 | 2.0 | 2.0 | signal |
| 120 | Hypocalcaemia | 13 | 2.0 | 2.0 | signal |
| 121 | Deafness | 18 | 2.0 | 2.0 | signal |
| 122 | Petechiae | 7 | 2.0 | 2.0 | no signal |
| 123 | Nasal Congestion | 39 | 2.0 | 2.0 | no signal |
| 124 | Tachypnoea | 9 | 1.9 | 2.0 | no signal |
| 125 | Pancytopenia | 37 | 1.9 | 2.0 | no signal |
| 126 | Drug Ineffective For Unapproved Indication | 37 | 1.9 | 2.0 | no signal |
| 127 | Osteomyelitis | 12 | 1.9 | 1.9 | no signal |
| 128 | Liver Injury | 16 | 1.9 | 1.9 | no signal |
| 129 | Liver Function Test Abnormal | 19 | 1.9 | 1.9 | no signal |
| 130 | Erythema Multiforme | 6 | 1.9 | 1.9 | no signal |
| 131 | Blood Creatinine Increased | 42 | 1.9 | 1.9 | no signal |
| 132 | Anhedonia | 17 | 1.9 | 1.9 | no signal |
| 133 | Lower Respiratory Tract Infection | 29 | 1.9 | 1.9 | no signal |
| 134 | Increased Appetite | 12 | 1.9 | 1.9 | no signal |
| 135 | Dialysis | 9 | 1.9 | 1.9 | no signal |
| 136 | Hepatic Failure | 19 | 1.8 | 1.8 | no signal |
| 137 | Nephropathy Toxic | 7 | 1.8 | 1.8 | no signal |
| 138 | Cholecystectomy | 7 | 1.8 | 1.8 | no signal |
| 139 | Ligament Sprain | 6 | 1.8 | 1.8 | no signal |
| 140 | Hepatomegaly | 6 | 1.8 | 1.8 | no signal |
| 141 | Palpitations | 71 | 1.8 | 1.8 | no signal |
| 142 | Rash Erythematous | 28 | 1.8 | 1.8 | no signal |
| 143 | Throat Tightness | 16 | 1.7 | 1.7 | no signal |
| 144 | Hypothermia | 6 | 1.7 | 1.7 | no signal |
| 145 | Dry Throat | 6 | 1.7 | 1.7 | no signal |
| 146 | Anxiety | 168 | 1.7 | 1.7 | no signal |
| 147 | Drug Level Decreased | 6 | 1.7 | 1.7 | no signal |
| 148 | Gamma-glutamyltransferase Increased | 13 | 1.7 | 1.7 | no signal |
| 149 | Device Related Infection | 9 | 1.7 | 1.7 | no signal |
| 150 | Blood Pressure Increased | 89 | 1.7 | 1.7 | no signal |
| 151 | Folliculitis | 6 | 1.7 | 1.7 | no signal |
| 152 | Cytokine Release Syndrome | 11 | 1.7 | 1.7 | no signal |
| 153 | Hypomagnesaemia | 8 | 1.7 | 1.7 | no signal |
| 154 | Hyperkalaemia | 20 | 1.7 | 1.7 | no signal |
| 155 | Myalgia | 97 | 1.7 | 1.7 | no signal |
| 156 | Anaphylactic Reaction | 31 | 1.7 | 1.7 | no signal |
| 157 | Lactic Acidosis | 18 | 1.6 | 1.6 | no signal |
| 158 | Electrocardiogram Qt Prolonged | 20 | 1.6 | 1.6 | no signal |
| 159 | International Normalised Ratio Increased | 16 | 1.6 | 1.6 | no signal |
| 160 | Skin Laceration | 6 | 1.6 | 1.6 | no signal |
| 161 | Brain Oedema | 7 | 1.6 | 1.6 | no signal |
| 162 | Haematuria | 19 | 1.6 | 1.6 | no signal |
| 163 | Pallor | 15 | 1.6 | 1.6 | no signal |
| 164 | Renal Impairment | 46 | 1.6 | 1.6 | no signal |
| 165 | Anaphylactic Shock | 14 | 1.6 | 1.6 | no signal |
| 166 | White Blood Cell Count Increased | 21 | 1.6 | 1.6 | no signal |
| 167 | Mental Status Changes | 15 | 1.6 | 1.6 | no signal |
| 168 | Bone Marrow Failure | 11 | 1.6 | 1.6 | no signal |
| 169 | Metabolic Acidosis | 17 | 1.6 | 1.6 | no signal |
| 170 | Lymphadenopathy | 19 | 1.6 | 1.6 | no signal |
| 171 | Upper Gastrointestinal Haemorrhage | 9 | 1.6 | 1.6 | no signal |
| 172 | Dyspnoea Exertional | 20 | 1.6 | 1.6 | no signal |
| 173 | Status Epilepticus | 6 | 1.6 | 1.6 | no signal |
| 174 | Myocarditis | 6 | 1.6 | 1.6 | no signal |
| 175 | Oropharyngeal Pain | 49 | 1.6 | 1.6 | no signal |
| 176 | Neutropenia | 71 | 1.5 | 1.5 | no signal |
| 177 | Post Procedural Complication | 10 | 1.5 | 1.5 | no signal |
| 178 | Chills | 61 | 1.5 | 1.5 | no signal |
| 179 | Neutrophil Count Decreased | 21 | 1.5 | 1.5 | no signal |
| 180 | Acute Hepatic Failure | 7 | 1.5 | 1.5 | no signal |
| 181 | Intentional Dose Omission | 14 | 1.5 | 1.5 | no signal |
| 182 | Abdominal Pain Upper | 105 | 1.5 | 1.5 | no signal |
| 183 | Mental Disorder | 22 | 1.5 | 1.5 | no signal |
| 184 | Nasopharyngitis | 93 | 1.5 | 1.5 | no signal |
| 185 | Myoclonus | 6 | 1.5 | 1.5 | no signal |
| 186 | Abscess | 8 | 1.5 | 1.5 | no signal |
| 187 | Blood Lactate Dehydrogenase Increased | 8 | 1.5 | 1.5 | no signal |
| 188 | Leukopenia | 25 | 1.5 | 1.5 | no signal |
| 189 | Inappropriate Antidiuretic Hormone Secretion | 5 | 1.4 | 1.4 | no signal |
| 190 | Sinusitis | 50 | 1.4 | 1.4 | no signal |
| 191 | Drug-induced Liver Injury | 15 | 1.4 | 1.4 | no signal |
| 192 | Weight Fluctuation | 5 | 1.4 | 1.4 | no signal |
| 193 | Brain Fog | 7 | 1.4 | 1.4 | no signal |
| 194 | Fear | 13 | 1.4 | 1.4 | no signal |
| 195 | Rash | 207 | 1.4 | 1.4 | no signal |
| 196 | Gastrointestinal Disorder | 42 | 1.4 | 1.4 | no signal |
| 197 | Serotonin Syndrome | 9 | 1.4 | 1.4 | no signal |
| 198 | Decreased Activity | 5 | 1.4 | 1.4 | no signal |
| 199 | Haemorrhage Intracranial | 7 | 1.4 | 1.4 | no signal |
| 200 | Renal Injury | 14 | 1.4 | 1.4 | no signal |
| 201 | Rhinorrhoea | 30 | 1.4 | 1.4 | no signal |
| 202 | Neurotoxicity | 8 | 1.4 | 1.4 | no signal |
| 203 | Pulmonary Thrombosis | 5 | 1.3 | 1.3 | no signal |
| 204 | Rhabdomyolysis | 19 | 1.3 | 1.3 | no signal |
| 205 | Complication Associated With Device | 6 | 1.3 | 1.3 | no signal |
| 206 | Skin Disorder | 15 | 1.3 | 1.3 | no signal |
| 207 | Tendonitis | 7 | 1.3 | 1.3 | no signal |
| 208 | Pancreatitis Acute | 10 | 1.3 | 1.3 | no signal |
| 209 | Nervous System Disorder | 14 | 1.3 | 1.3 | no signal |
| 210 | Rash Papular | 10 | 1.3 | 1.3 | no signal |
| 211 | Product Dose Omission | 29 | 1.3 | 1.3 | no signal |
| 212 | Blood Glucose Decreased | 21 | 1.3 | 1.3 | no signal |
| 213 | Hypoglycaemia | 21 | 1.3 | 1.3 | no signal |
| 214 | Oral Discomfort | 6 | 1.3 | 1.3 | no signal |
| 215 | Product Packaging Issue | 4 | 1.3 | 1.3 | no signal |
| 216 | Vasculitis | 5 | 1.3 | 1.3 | no signal |
| 217 | Dysphonia | 25 | 1.3 | 1.3 | no signal |
| 218 | Splenomegaly | 5 | 1.3 | 1.3 | no signal |
| 219 | Unevaluable Event | 32 | 1.2 | 1.2 | no signal |
| 220 | Cardiac Arrest | 35 | 1.2 | 1.2 | no signal |
| 221 | Skin Exfoliation | 35 | 1.2 | 1.2 | no signal |
| 222 | Covid-19 Pneumonia | 5 | 1.2 | 1.2 | no signal |
| 223 | Depressed Mood | 22 | 1.2 | 1.2 | no signal |
| 224 | Fluid Overload | 6 | 1.2 | 1.2 | no signal |
| 225 | Flatulence | 23 | 1.2 | 1.2 | no signal |
| 226 | Hepatic Function Abnormal | 15 | 1.2 | 1.2 | no signal |
| 227 | No Therapeutic Response | 5 | 1.2 | 1.2 | no signal |
| 228 | Adverse Drug Reaction | 36 | 1.2 | 1.2 | no signal |
| 229 | Gastric Disorder | 14 | 1.2 | 1.2 | no signal |
| 230 | Sluggishness | 4 | 1.2 | 1.2 | no signal |
| 231 | Eye Discharge | 4 | 1.1 | 1.1 | no signal |
| 232 | Treatment Failure | 32 | 1.1 | 1.1 | no signal |
| 233 | Maternal Exposure During Pregnancy | 34 | 1.1 | 1.1 | no signal |
| 234 | Acute Myeloid Leukaemia | 6 | 1.1 | 1.1 | no signal |
| 235 | Accidental Overdose | 14 | 1.1 | 1.1 | no signal |
| 236 | Platelet Count Increased | 5 | 1.1 | 1.1 | no signal |
| 237 | Transfusion | 4 | 1.1 | 1.1 | no signal |
| 238 | Middle Insomnia | 7 | 1.1 | 1.1 | no signal |
| 239 | Sars-cov-2 Test Positive | 5 | 1.1 | 1.1 | no signal |
| 240 | Cerebral Infarction | 9 | 1.1 | 1.1 | no signal |
| 241 | Mania | 6 | 1.1 | 1.1 | no signal |
| 242 | Premature Baby | 11 | 1.1 | 1.1 | no signal |
| 243 | Angioedema | 16 | 1.1 | 1.1 | no signal |
| 244 | Cytomegalovirus Infection | 6 | 1.1 | 1.1 | no signal |
| 245 | Circumstance Or Information Capable Of Leading To Medication Error | 12 | 1.0 | 1.0 | no signal |
| 246 | Interstitial Lung Disease | 17 | 1.0 | 1.0 | no signal |
| 247 | Death | 302 | 1.0 | 1.0 | no signal |
| 248 | Anosmia | 5 | 1.0 | 1.0 | no signal |
| 249 | Peritonitis | 7 | 1.0 | 1.0 | no signal |
| 250 | Polyneuropathy | 4 | 1.0 | 1.0 | no signal |
| 251 | Gastrointestinal Haemorrhage | 28 | 1.0 | 1.0 | no signal |
| 252 | Suicidal Ideation | 30 | 1.0 | 1.0 | no signal |
| 253 | Influenza Like Illness | 27 | 1.0 | 1.0 | no signal |
| 254 | Emotional Disorder | 10 | 0.9 | 0.9 | no signal |
| 255 | Pharyngeal Oedema | 5 | 0.9 | 0.9 | no signal |
| 256 | Anorexia | 4 | 0.9 | 0.9 | no signal |
| 257 | Pneumocystis Jirovecii Pneumonia | 3 | 0.9 | 0.9 | no signal |
| 258 | Abortion Spontaneous | 12 | 0.9 | 0.9 | no signal |
| 259 | Injection Site Discomfort | 3 | 0.9 | 0.9 | no signal |
| 260 | Product Storage Error | 24 | 0.8 | 0.8 | no signal |
| 261 | Blood Glucose Abnormal | 5 | 0.8 | 0.8 | no signal |
| 262 | Anger | 9 | 0.8 | 0.8 | no signal |
| 263 | Delusion | 4 | 0.8 | 0.8 | no signal |
| 264 | Caesarean Section | 3 | 0.7 | 0.7 | no signal |
| 265 | Mood Swings | 8 | 0.7 | 0.7 | no signal |
| 266 | Incorrect Route Of Drug Administration | 9 | 0.7 | 0.7 | no signal |
| 267 | Product Preparation Error | 5 | 0.7 | 0.7 | no signal |
| 268 | Local Swelling | 4 | 0.7 | 0.7 | no signal |
| 269 | Acne | 17 | 0.7 | 0.7 | no signal |
| 270 | Drug Toxicity | 3 | 0.6 | 0.6 | no signal |
| 271 | Pulmonary Arterial Hypertension | 3 | 0.6 | 0.6 | no signal |
| 272 | Glycosylated Haemoglobin Increased | 5 | 0.6 | 0.6 | no signal |
| 273 | Drug Administration Error | 6 | 0.6 | 0.6 | no signal |
| 274 | Amenorrhoea | 3 | 0.5 | 0.5 | no signal |
| 275 | Foetal Exposure During Pregnancy | 13 | 0.5 | 0.5 | no signal |
| 276 | Menorrhagia | 3 | 0.4 | 0.4 | no signal |
| 277 | Exposure Via Skin Contact | 3 | 0.4 | 0.4 | no signal |
| 278 | Wrong Technique In Drug Usage Process | 4 | 0.3 | 0.3 | no signal |
| 279 | Breast Cancer | 10 | 0.3 | 0.3 | no signal |
| 280 | Device Dislocation | 4 | 0.3 | 0.3 | no signal |
| 281 | Device Issue | 8 | 0.3 | 0.3 | no signal |
| 282 | Myelosuppression | 3 | 0.3 | 0.3 | no signal |